I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 9 studies | 37% ± 23% | |
| T cell | 8 studies | 23% ± 6% | |
| B cell | 6 studies | 28% ± 9% | |
| glutamatergic neuron | 6 studies | 22% ± 5% | |
| plasmablast | 5 studies | 36% ± 18% | |
| erythroblast | 5 studies | 38% ± 20% | |
| erythrocyte | 5 studies | 47% ± 15% | |
| natural killer cell | 5 studies | 34% ± 12% | |
| pro-B cell | 4 studies | 29% ± 13% | |
| epithelial cell | 4 studies | 28% ± 4% | |
| dendritic cell | 4 studies | 31% ± 15% | |
| CD8-positive, alpha-beta T cell | 4 studies | 30% ± 2% | |
| deuterosomal cell | 3 studies | 22% ± 4% | |
| cholangiocyte | 3 studies | 21% ± 4% | |
| macrophage | 3 studies | 52% ± 24% | |
| hepatocyte | 3 studies | 21% ± 1% | |
| neuron | 3 studies | 33% ± 22% | |
| fibroblast | 3 studies | 40% ± 21% | |
| ciliated cell | 3 studies | 32% ± 22% | |
| hematopoietic precursor cell | 3 studies | 26% ± 5% | |
| astrocyte | 3 studies | 26% ± 12% | |
| CD4-positive, alpha-beta T cell | 3 studies | 37% ± 3% |
